Gut Microbiome Modulation through Probiotics and Prebiotics for Metabolic Health: A Narrative Review

Authors

  • Wahyu Aulia Hasibuan Universitas Internasional Batam
  • Miftahul Jannah Universitas Internasional Batam
  • Prananingrum Kinasih Universitas Internasional Batam
  • Adelia Paradya Zetta Universitas Internasional Batam

DOI:

https://doi.org/10.37253/nurish.v1i2.12447

Keywords:

gut microbiota, insulin resistance, metabolic syndrome, prebiotics, probiotics

Abstract

Background: The gut microbiome plays a central role in host energy harvest, glucose homeostasis, and inflammation, and its disruption (dysbiosis) is implicated in obesity, type 2 diabetes mellitus (T2DM), and related cardiometabolic disorders. Probiotics and prebiotics have been investigated as accessible dietary strategies to modulate the microbiome and improve metabolic outcomes. This narrative review synthesizes evidence on mechanisms linking gut microbiota to metabolic health and evaluates the clinical efficacy of probiotic and prebiotic interventions in obesity and T2DM.

Methods: A non-systematic search was performed in PubMed, Web of Science, and the Cochrane Library for systematic reviews, meta-analyses of randomized controlled trials (RCTs), and key mechanistic studies published within the last ten years, using terms related to gut microbiota, probiotics, prebiotics, synbiotics, short-chain fatty acids, and metabolic disease.

Results: Dysbiosis is characterized by reduced microbial diversity, diminished short-chain fatty acid production, impaired intestinal barrier integrity, and metabolic endotoxemia, collectively promoting low-grade inflammation and insulin resistance. Multiple meta-analyses of RCTs show that probiotic and synbiotic supplementation modestly but significantly reduces fasting glucose, HbA1c, and insulin resistance in T2DM, with more consistent effects for multi-strain, capsule-based formulations than fermented dairy vehicles. Emerging evidence on next-generation probiotics, particularly pasteurized Akkermansia muciniphila, shows improved insulin sensitivity and lipid profile in overweight and obese adults.

Conclusion: Probiotic and prebiotic interventions offer a biologically plausible, low-risk adjunct for metabolic disease management, though effect sizes remain modest and strain-, dose-, and duration-dependent, warranting cautious interpretation and further long-term trials.

Downloads

Download data is not yet available.

Downloads

Published

2026-06-12

Issue

Section

Articles